A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis

Abstract: Multiple myeloma is, in most patients, an incurable cancer. Its precursors can be identified with routine tests setting the stage for early intervention to prevent active myeloma. We investigated the efficacy and safety of pembrolizumab, an antiprogrammed cell death 1 antibody, in smolderi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Elisabet E. Manasanch, Guangchun Han, Rohit Mathur, Yun Qing, Zheng Zhang, Hans Lee, Donna M. Weber, Behrang Amini, Zuzana Berkova, Karina Eterovic, Shaojun Zhang, Jianhua Zhang, Xingzhi Song, Xizeng Mao, Margaret Morgan, Lei Feng, Veera Baladandayuthapani, Andrew Futreal, Linghua Wang, Sattva S. Neelapu, Robert Z. Orlowski
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2019-08-01
Schriftenreihe:	Blood Advances
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2473952920306364
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!